… Effects of fluoxetine and venlafaxine on serum brain-derived neurotrophic factor levels in
depressed patients. Prog Neuro-Psychopharmacol Biol Psychiatry 2009; 33: 281–285. …

… depressive disorder or anxiety disorder in the last 6 months (n = 1.688) and those who were
using any kind of antidepressant medication … of technical problems: ie not enough blood was …

… Brain-Derived Neurotrophic Factor (BDNF) is a neurotrophin that has been linked to the
viability of neurons in brain circuits that regulate emotion, memory, learning, sleep and appetite (…

… depressive disorder: state-trait issues, clinical features and pharmacological treatment. Mol
… (pBDNF) and outcome to acute antidepressant treatment in patients with Major Depression. …

… ), has been attracting growing attention in relation to major depressive disorder (MDD). The
“… depressive disorder: state and trait issues, clinical features, and pharmacological treatment. …

… , somatic diseases and medication use, BDNF levels were … associated with clinical improvement
(Molendijk et al., 2011). … testing blood BDNF levels in MDD with melancholic features, …

… specific medication for this lipid abnormality, and fasting plasma … lower serum BDNF levels
in patients with major depressive … problems between the actual level of depressive symptoms …

… However, the issue of the best source (plasma vs. … of antidepressant drug through serum
concentrations, blood was withdrawn in the morning, at least 12 h after the last daily drug intake, …

… to neuroplasticity is brain-derived neurotrophic factor (BDNF). … /DSM-IV unipolar major
depression of at least moderate severity … to a lower serum BDNF level in drug na�ve individuals at …

… Serum BDNF levels are decreased in major depression and tend to normalize under
antidepressant treatment (… may differ between specific antidepressants (Molendijk et al. 2011). …